MAXIA PHARMACEUTICALS
Maxia Pharmaceuticals is a privately-held drug discovery and development company that specialized in small molecule drugs.
MAXIA PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical
Address:
San Diego, California, United States
Country:
United States
Status:
Active
Contact:
(858)824-1988
Total Funding:
0
Similar Organizations
DS Biopharma
DS Biopharma is a privately held drug discovery and development company.
MerLion Pharma
MerLion Pharmaceuticals is a drug discovery and development company that researches and develops natural products.
NanoPacific Holdings
NanoPacific Holdings (NPH) is a privately held research and development company based in Los Angeles,
Promiliad Biopharma
Promiliad Biopharma is an innovative drug discovery company that creates novel natural product-like small molecules.
Investors List
Bay City Capital
Bay City Capital investment in Venture Round - Maxia Pharmaceuticals
More informations about "Maxia Pharmaceuticals"
Maxia Pharmaceuticals - Crunchbase Company Profile & Funding
Maxia Pharmaceuticals is a privately-held drug discovery and development company that specialized in small molecule drugs. Maxia Pharmaceuticals was acquired by Incyte on Feb …See details»
Maxia Pharmaceuticals Inc - Company Profile and News
Maxia Pharmaceuticals, Inc. is a privately-held biotechnology company based in San Diego, California, that discovers and develops novel small molecule therapeutics.See details»
Maxia Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Maxia Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 4 literature, Drug:MX-6162, MX-895, MX-781, MX-7091, MX-6043.See details»
Maxia Pharmaceuticals - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Maxia Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Maxia Pharmaceuticals - Crunchbase
Maxia Pharmaceuticals is a privately-held drug discovery and development company that specialized in small molecule drugs.See details»
Maxia Pharmaceuticals - Funding, Financials, Valuation & Investors
Maxia Pharmaceuticals is a privately-held drug discovery and development company that specialized in small molecule drugs.See details»
Incyte Announces Agreement to Acquire Maxia Pharmaceuticals
MAXIA Pharmaceuticals, Inc. is a privately-held biotechnology company based in San Diego, California, that discovers and develops novel small molecule therapeutics. The company is …See details»
Incyte in $43M deal to buy Maxia Pharma - Pharmaceutical …
Mar 3, 2003 · California, USA-based Incyte Genomics has completed the acquisition ofprivately-held drug discovery firm Maxia Pharmaceuticals in a deal worth around $43 million. Under the …See details»
Maxia Pharmaceuticals, Inc.:Company Profile & Technical Research ...
Maxia Pharmaceuticals Inc is a company that provides Drug discovery, Medicine, Molecule and more. Maxia Pharmaceuticals Inc is headquartered in United States California. Maxia …See details»
Maxia Pharma - Bay City Capital
Maxia Pharma Formed to exploit the non-dermatological applications of a patented library of compounds licensed from Galderma. The company focused on small molecule drugs that …See details»
Maxia Pharmaceuticals - Products, Competitors, Financials, …
Maxia Pharmaceuticals was a Healthcare/Pharmaceuticals / Drugs company based in San Diego, California. Maxia Pharmaceuticals was acquired in 2003. You're one click away from the most …See details»
Incyte Buying Maxia For $28.3M; Plans Staff, Expense Reductions
Nov 13, 2002 · Incyte Genomics Inc., known for its databases and research solutions, is acquiring Maxia Pharmaceuticals Inc. and its pipeline of early stage drugs for an amount that could …See details»
Maxia Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
Feb 17, 2003 · See Maxia Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Maxia Pharmaceuticals's post-money valuation and …See details»
Incyte acquires Maxia Pharmaceuticals - 2003-02-18 - Crunchbase
Feb 18, 2003 · Acquiring Organization: Incyte Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs. …See details»
Maxia Pharmaceuticals - CB Insights
Explore {Maxia Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
MX-7220 - Drug Targets, Indications, Patents - Synapse - Patsnap
Understand key drug designations in just a few clicks with Synapse. MX-7220, Initially developed by Maxia Pharmaceuticals, Inc., Now, its global highest R&D status is Discontinued, …See details»
MX-895 - Drug Targets, Indications, Patents - Synapse - Patsnap
MX-895, Initially developed by Maxia Pharmaceuticals, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Neoplasms,Skin and Musculoskeletal Diseases.See details»
Maxima Pharmaceuticals - Crunchbase Company Profile & Funding
Maxima Pharmaceuticals researches and manufactures various types of medicines. A pluronic lecithin organogel (PLO) used as a vehicle for pharmaceutical compounding, compatible with a …See details»
Medisca Acquires all IP assets of Maxima Pharmaceuticals …
DIFFUSIMAX® and DIFFUSIMAX®10 will continue to be manufactured in Edmonton, Alberta under the current Maxima leadership team and will be offered in both Pre-Mixed Cream and …See details»
MX-7091 - Drug Targets, Indications, Patents - Synapse - Patsnap
MX-7091: a DUSP1 inhibitors Drug, Initially developed by Maxia Pharmaceuticals, Inc., Now, its global highest R&D status is Discontinued, Mechanism: DUSP1 inhibitors (Dual specificity …See details»